Inhibition of the intestinal FXR-SMPD3 axis has been shown to improve atherosclerosis (21), while activation of TGR5 can inhibit atherosclerosis by reducing macrophage inflammation and lipid accumulation (22). The gene discussed is GPBAR1; the disease is atherosclerosis.